The Learning Portal will be under maintenance Saturday, 8 August between 6 AM and 6 PM EST. Portal functionality will be unavailable during this window.
We apologize for any inconvenience caused during this time.

RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
  • US Regulators Consider Formation of New Advisory Subcommittee to Study 'Data Liberation'

    The US Food and Drug Administration's (FDA) Science Board-an advisory board focused on the mission and competencies of the agency-will soon meet to start the process of reassessing a landmark 2007 report in which it described FDA as being in a state of decline. Background The report, FDA Science and Mission at Risk , was prepared in 2007 by the Science Board's Subcommittee on Science and Technology. In it, the board raised three principal points against FDA: that i...
  • Agency Deficiencies Focus of Newly Proposed Scientific Subcommittee

    The US Food and Drug Administration's (FDA) Science Board will consider a motion to establish a new subcommittee at an October 2012 meeting that will seek to revisit some of the problems raised in a landmark 2007 report about scientific deficiencies at FDA. That report, FDA Science and Mission at Risk (2007), was prepared by the Science Board's Subcommittee on Science and Technology, and leveled three charges against FDA: Its scientific base is weak and eroding...